Outside Views on Biodefense for the Department of Defense, Hearing Before the Subcommittee on Emerging Threats and Capabilities of the Committee on Armed Services, U.S. House of Representatives, One Hundred Fourteenth Congress, Second Session, February 3, 2016 [open pdf - 1MB]
This is from the February 3, 2016 hearing on "Outside Views on Biodefense for the Department of Defense" held before the House Committee on Armed Services. From the opening statement of Joe Wilson: "This hearing will provide an overview of the findings and recommendations from the recent bipartisan report of the Blue Ribbon Study Panel on Biodefense. It is critical that the United States maintain a dynamic national defense against the growing threat posed by biological weapons and naturally occurring diseases. The Department of Defense plays a large role in the U.S. biodefense enterprise, contributing biodetection tools, medical countermeasures and protection, and decontamination technologies. The recent response to the Ebola outbreak illustrates the importance of the Department of Defense's biodefense contributions to broader government and global efforts. This hearing is especially timely in preparing for our subcommittee hearing next week with the Department of Defense on countering weapons of mass destruction policy and programs for the fiscal year 2017. The findings and recommendations discussed today will be important aspects of our review of the fiscal year 2017 Department of Defense biodefense enterprise." Statements, letters, and materials submitted for the record include those of the following: Gerald W. Parker Jr., and Kenneth L. Wainstein.
H.A.S.C. No. 114-85; House Armed Services Committee: 114-85
Government Publishing Office: https://www.gpo.gov/